Phibro Animal Health Corporation (PAHC) - Total Assets

Latest as of March 2026: $1.45 Billion USD

Based on the latest financial reports, Phibro Animal Health Corporation (PAHC) holds total assets worth $1.45 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Phibro Animal Health Corporation - Total Assets Trend (2000–2025)

This chart illustrates how Phibro Animal Health Corporation's total assets have evolved over time, based on quarterly financial data. Also see Phibro Animal Health Corporation (PAHC) total market value for the company's overall valuation and market capitalisation.

Phibro Animal Health Corporation - Asset Composition Analysis

Current Asset Composition (June 2025)

Phibro Animal Health Corporation's total assets of $1.45 Billion consist of 59.6% current assets and 40.4% non-current assets. Review PAHC total liabilities to assess the company's total debt and financial obligations.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 5.0%
Accounts Receivable $227.98 Million 16.8%
Inventory $444.43 Million 32.7%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $36.47 Million 2.7%
Goodwill $59.65 Million 4.4%

Asset Composition Trend (2000–2025)

This chart illustrates how Phibro Animal Health Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Phibro Animal Health Corporation stock quote for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Phibro Animal Health Corporation's current assets represent 59.6% of total assets in 2025, an increase from 58.0% in 2000.
  • Cash Position: Cash and equivalents constituted 5.0% of total assets in 2025, up from 0.9% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 2.0% in 2000.
  • Asset Diversification: The largest asset category is inventory at 32.7% of total assets.

Phibro Animal Health Corporation Competitors by Total Assets

Key competitors of Phibro Animal Health Corporation based on total assets are shown below.

Company Country Total Assets
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
USA $15.42 Trillion
Takeda Pharmaceutical Company Limited
F:TKDA
Germany €15.41 Trillion
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
China CN¥68.33 Billion
Viatris Inc
NASDAQ:VTRS
USA $35.04 Billion
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
China CN¥17.84 Billion
Neuland Laboratories Limited
NSE:NEULANDLAB
India Rs29.30 Billion
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131
China CN¥6.49 Billion
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436
China CN¥1.41 Billion

Phibro Animal Health Corporation - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.17 2.91 3.04
Quick Ratio 1.26 1.23 1.72
Cash Ratio 0.00 0.00 0.00
Working Capital $612.20 Million $509.54 Million $334.79 Million

Phibro Animal Health Corporation - Advanced Valuation Insights

This section examines the relationship between Phibro Animal Health Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.84
Latest Market Cap to Assets Ratio 0.59
Asset Growth Rate (YoY) 38.6%
Total Assets $1.36 Billion
Market Capitalization $805.88 Million USD

Valuation Analysis

Below Book Valuation: The market values Phibro Animal Health Corporation's assets below their book value (0.59x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Phibro Animal Health Corporation's assets grew by 38.6% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Phibro Animal Health Corporation (2000–2025)

The table below shows the annual total assets of Phibro Animal Health Corporation from 2000 to 2025.

Year Total Assets Change
2025-06-30 $1.36 Billion +38.56%
2024-06-30 $982.18 Million +1.11%
2023-06-30 $971.40 Million +4.26%
2022-06-30 $931.70 Million +10.74%
2021-06-30 $841.33 Million +7.30%
2020-06-30 $784.10 Million +7.90%
2019-06-30 $726.67 Million +8.19%
2018-06-30 $671.68 Million +7.74%
2017-06-30 $623.40 Million +2.13%
2016-06-30 $610.37 Million +23.73%
2015-06-30 $493.32 Million +4.45%
2014-06-30 $472.32 Million -0.38%
2013-06-30 $474.14 Million +7.54%
2012-06-30 $440.91 Million +21.92%
2009-06-30 $361.63 Million +11.24%
2008-06-30 $325.07 Million +19.56%
2007-06-30 $271.90 Million +9.50%
2006-06-30 $248.30 Million -1.90%
2005-06-30 $253.10 Million +4.85%
2004-06-30 $241.40 Million -11.99%
2003-06-30 $274.30 Million -7.46%
2002-06-30 $296.40 Million -10.18%
2001-06-30 $330.00 Million +27.66%
2000-06-30 $258.50 Million --

About Phibro Animal Health Corporation

NASDAQ:PAHC USA Drug Manufacturers - Specialty & Generic
Market Cap
$805.88 Million
Market Cap Rank
#9969 Global
#2696 in USA
Share Price
$38.25
Change (1 day)
-0.86%
52-Week Range
$28.52 - $59.58
All Time High
$59.58
About

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including po… Read more